Benjamin Scaria

Mr. Benjamin Scaria

University of Windsor. Department of Chemistry and Biochemistry. 401 Sunset Avenue, N9B 3P4. Windsor, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2019 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
CNChristopher Nguyen
Christopher Nguyen
KBKiruthika Baskaran
Kiruthika Baskaran
APAlaina Pupulin
Alaina Pupulin
IRIvan Ruvinov
Ivan Ruvinov
OZOla Zaitoon
Ola Zaitoon
SPSiyaram Pandey
Siyaram Pandey
Current therapeutic approaches to treat metastatic breast cancer, although effective, have shown many inadvertent side effects such as genotoxicity due to a lack of selectivity. Thus, these treatment plans are not suitable for long-term usage. Natural health product extracts are safe for long-term consumption and some have shown to be medicinally active containing multiple bioactive compounds able target multiple vulnerabilities in cancer. One of which, Hibiscus rosa-sinesis (hibiscus) extract, has been reported to have many medicinal and anticancer properties due to its antioxidant and hypolipidemic effects. However, its efficacy against breast cancer has not been fully investigated and characterized. If effective against cancer, hibiscus extract could potentially be combined with chemotherapeutic treatments in adjuvant therapy to reduce chemotherapy-inducing side effects. We have investigated aqueous hibiscus flower extract anticancer efficacy, selectivity, and interactions with chemotherapeutics taxol, cisplatin, and tamoxifen in estrogen-receptor positive breast cancer cells, triple-negative human breast cancer cells, and normal non-cancerous cells. Apoptotic morphology and biochemical marker expression were assessed to determine the extent anticancer efficacy of hibiscus. Mitochondrial membrane potential reduction and reactive oxygen species generation were quantified using fluorogenic dyes to determine the mechanism of hibiscus extract action. Hibiscus extract was able to selectively induce apoptosis in both triple-negative and estrogen-receptor positive breast cancer cells in a dosage-dependent manner. Most importantly, addition of hibiscus extract was found to enhance the induction of apoptosis of chemotherapy treatments (taxol and cisplatin) in triple-negative breast cancer cells when compared to treatment alone. Moreover, hibiscus extract addition to chemotherapy treatment was able to increase oxidative stress and decrease mitochondrial membrane potential compared to individual treatments. Hibiscus extract is effective on breast cancer, most notably on generally resistant triple-negative breast cancer, while being selective for normal healthy cells. Hibiscus extract could supplement chemotherapeutic regimens as an adjuvant and lead to a more efficacious treatment approach to reduce chemotherapy dosages and related toxicity.

Verified
Journal Article
Open access
PDF file
BSBenjamin Scaria
Benjamin Scaria
SSSiddhartha Sood
Siddhartha Sood
CRChristopher Raad
Christopher Raad
JKJana Khanafer
Jana Khanafer
RJRahul Jayachandiran
Rahul Jayachandiran
SPSiyaram Pandey
Siyaram Pandey
Most cancer therapeutics, such as tubulin-targeting chemotherapy drugs, cause cytotoxic, non-selective effects. These harmful side-effects drastically reduce the cancer patient’s quality of life. Recently, researchers have focused their efforts on studying natural health products (NHP’s) which have demonstrated the ability to selectively target cancer cells in cellular and animal models. However, the major hurdle of clinical validation remains. NHP’s warrant further clinical investigation as a therapeutic option since they exhibit low toxicity, while retaining a selective effect. Additionally, they can sensitize cancerous cells to chemotherapy, which enhances the efficacy of chemotherapeutic drugs, indicating that they can be utilized as supplemental therapy. An additional area for further research is the investigation of drug–drug interactions between NHP’s and chemotherapeutics. The objectives of this review are to report the most recent results from the field of anticancer NHP research, and to highlight the most recent advancements in possible supplemental therapeutic options.

1 January 2019 in Integrative Cancer Therapies
Verified
Journal Article
Open access
PDF file
IRIvan Ruvinov
Ivan Ruvinov
CNChristopher Nguyen
Christopher Nguyen
BSBenjamin Scaria
Benjamin Scaria
CVCaleb Vegh
Caleb Vegh
OZOla Zaitoon
Ola Zaitoon
SPSiyaram Pandey
Siyaram Pandey
Current chemotherapeutics for metastatic colorectal cancers have limited success and are extremely toxic due to nonselective targeting. Some natural extracts have been traditionally taken and have shown anticancer activity. These extracts have multiple phytochemicals that can target different pathways selectively in cancer cells. We have shown previously that lemongrass ( Cymbopogon citratus) extract is effective at inducing cell death in human lymphomas. However, the efficacy of lemongrass extract on human colorectal cancer has not been investigated. Furthermore, its interactions with current chemotherapies for colon cancer is unknown. In this article, we report the anticancer effects of ethanolic lemongrass extract in colorectal cancer models, and importantly, its interactions with FOLFOX and Taxol. Lemongrass extract induced apoptosis in colon cancer cells in a time and dose-dependent manner without harming healthy cells in vitro. Oral administration of lemongrass extract was well tolerated and effective at inhibiting colon cancer xenograft growth in mice. It enhanced the anticancer efficacy of FOLFOX and, interestingly, inhibited FOLFOX-related weight loss in animals given the combination treatment. Furthermore, feeding lemongrass extract to APCmin/+ transgenic mice led to the reduction of intestinal tumors, indicating its preventative potential. Therefore, this natural extract has potential to be developed as a supplemental treatment for colorectal cancer.

17 July 2019 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
CNChristopher Nguyen
Christopher Nguyen
AMAli Mehaidli
Ali Mehaidli
KBKiruthika Baskaran
Kiruthika Baskaran
SGSahibjot Grewal
Sahibjot Grewal
APAlaina Pupulin
Alaina Pupulin
SPSiyaram Pandey
Siyaram Pandey
Many conventional chemotherapies have indicated side effects due to a lack of treatment specificity and are thus not suitable for long-term usage. Natural health products are well-tolerated and safe for consumption, and some have pharmaceutical uses particularly for their anticancer effects. We have previously reported the anticancer efficacy of dandelion (Taraxacum officinale) root and lemongrass (Cymbopogon citratus) extracts. However, their efficacy on prostate cancer and their interactions with standard chemotherapeutics have not been studied to determine if they will be suitable for adjuvant therapies. If successful, these extracts could potentially be used in conjunction with chemotherapeutics to minimize the risk of drug-related toxicity and enhance the efficacy of the treatment. We have demonstrated that both dandelion root extract (DRE) and lemongrass extract (LGE) exhibit selective anticancer activity. Importantly, DRE and LGE addition to the chemotherapeutics taxol and mitoxantrone was determined to enhance the induction of apoptosis when compared to individual chemotherapy treatment alone. Further, DRE and LGE were able to significantly reduce the tumour burden in prostate cancer xenograft models when administered orally, while also being well-tolerated. Thus, the implementation of these well-tolerated extracts in adjuvant therapies could be a selective and efficacious approach to prostate cancer treatment.

13 April 2018
Verified
Conference Paper
Open access
IRI Ruvinov
I Ruvinov
CPC Philion
C Philion
BSBenjamin Scaria
Benjamin Scaria
CNC Nguyen
C Nguyen
KBK Baskaran
K Baskaran
SPS Pandey
S Pandey
The problem with conventional cancer treatments is that the drugs used are not selective towards cancer and in turn are toxic to healthy cells. New therapeutic development should target vulnerabilities that are unique to cancer cells that can trigger cell death. Numerous natural extracts and compounds have been reported to have efficacious medicinal properties with selective activity towards various diseases. Dandelion (Taraxacum spp) root and lemongrass (Cymbopogon citratus) extracts each contain multiple bioactive compounds and have been shown to target multiple pathways in cancer cells to selectively induce apoptosis. Recent work in our lab shows that lemongrass and white tea extracts possess the ability to selectively induce apoptosis in lymphoma and leukemia models. Herein, we report the anticancer properties of ethanolic lemongrass extract in colorectal cancer models. These extracts are to be tested for possible interactions with existing colorectal cancer chemotherapy drugs. Additionally, none of these extracts have been examined for their efficacy in tumour-bearing transgenic mice. Therefore, our objective is to utilize a transgenic animal model to demonstrate the ability of these extracts to inhibit the onset of colon cancer. Thus, utilizing natural extracts could be a potential means to treating and/or preventing the occurrence of cancer in a non-toxic manner without disrupting chemotherapeutic treatments. Most importantly, since these extracts are well-tolerated, they can be taken over long periods of time, decreasing the chances of relapse.